Endocrinologists and nephrologists managing type 1 diabetes patients often focus on tight glycemic control and retinopathy screening, but real-world data from Salford, Greater Manchester reveals chronic kidney disease affects up to 47% of these adults despite modern insulin therapies, underscoring gaps in renoprotective care that demand immediate attention in busy diabetes clinics. 
In this study published in the Diabetic Medicine, the researchers conducted a retrospective cohort study using anonymized electronic health records from the Salford Integrated Record Research Database, tracking 1,106 adults with type 1 diabetes between 2010 and 2023. They defined CKD as estimated glomerular filtration rate below 60 mL/min/1.73m² and/or albuminuria with urine albumin-to-creatinine ratio of 3 mg/mmol or higher, confirmed by two readings at least 90 days apart to avoid transient abnormalities. 
Alarming Prevalence Demands Action
Among the cohort, 38.5% developed reduced eGFR, 47.2% showed albuminuria, and 23.8% met both criteria for definite CKD, confirming kidney disease remains a dominant complication even in the insulin pump and CGM era, with nearly half of patients facing albuminuria that signals rapid progression risk.
Age Drives eGFR Decline Relentlessly
Older age emerged as the strongest predictor of reduced eGFR, with individuals aged 42-54 years facing sub-distribution hazard ratio of 3.1 (95% CI 2.0-5.0) and those 55 years or older reaching 8.6 (95% CI 5.4-13.9) compared to the 18-28 year reference group, highlighting cumulative glycemic exposure's devastating toll that intensifies after age 40.
Modifiable Risks Compound the Threat
Additional eGFR decline factors included missing ethnicity data with sub-distribution hazard ratio (sHR) 1.5, higher BMI increasing risk by 1.1 per kg/m² increment, elevated HbA1c worsening odds by 1.1 per mmol/mol, and absence of ACE inhibitor or ARB prescription carrying sHR 1.4, all reinforcing familiar targets where clinic interventions yield highest returns.
Albuminuria Patterns Differ Sharply
Albuminuria risk factors diverged notably, with female sex conferring sHR 1.3, missing ethnicity data sHR 1.4, higher HbA1c sHR 1.1 per mmol/mol, current smoking sHR 1.5, residence in the second most deprived quintile sHR 1.9, and ACE inhibitor/ARB prescription paradoxically showing sHR 2.1, suggesting these drugs identify higher-risk patients already exhibiting early protein leak.
Diabetes Clinic Transformation
In type 1 patients over age 42 with BMI above 27, the endocrinologists may recommend annual albumin-creatinine ratio alongside eGFR, push smoking cessation counseling, titrate HbA1c below 7%, and start renoprotective therapy early regardless of blood pressure, as Salford data prove these steps slash CKD progression in real-world settings.